Ubs Asset Management Americas Inc Exact Sciences Corp Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,314,470 shares of EXAS stock, worth $56.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,314,470

Previous 780,839 68.34%

Holding current value

$56.8 Million

Previous $57.8 Million 57.15%

% of portfolio

0.03%

Previous 0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $30 Million - $39.4 Million	533,631 Added 68.34%	1,314,470 $90.8 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $3.5 Million - $4.49 Million	59,236 Added 8.21%	780,839 $57.8 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $7.69 Million - $11.6 Million	116,677 Added 19.29%	721,603 $49.2 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $1.1 Million - $1.65 Million	23,367 Added 4.02%	604,926 $41 Million
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $58,696 - $102,792	-1,934 Reduced 0.33%	581,559 $28.8 Million

Q3 2022 Nov 14, 2022	SELL	$31.97 - $49.37 $1.03 Million - $1.59 Million	-32,190 Reduced 5.23%	583,493 $19 Million
Q2 2022 Aug 12, 2022	SELL	$35.61 - $76.23 $1.05 Million - $2.25 Million	-29,569 Reduced 4.58%	615,683 $24.3 Million
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $1.13 Million - $1.62 Million	19,644 Added 3.14%	645,252 $45.1 Million
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $956,420 - $1.33 Million	13,192 Added 2.15%	625,608 $48.7 Million
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $1.11 Million - $1.52 Million	12,266 Added 2.04%	612,416 $58.5 Million
Q2 2021 Aug 16, 2021	BUY	$93.66 - $139.27 $4.69 Million - $6.98 Million	50,097 Added 9.11%	600,150 $74.6 Million
Q1 2021 May 14, 2021	BUY	$116.57 - $155.01 $5.33 Million - $7.08 Million	45,694 Added 9.06%	550,053 $72.5 Million
Q4 2020 Mar 01, 2021	BUY	$99.61 - $142.12 $4.19 Million - $5.98 Million	42,088 Added 9.1%	504,359 $66.8 Million
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $514,013 - $719,068	-7,049 Reduced 1.5%	462,271 $47.1 Million
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $6.03 Million - $10 Million	-108,099 Reduced 18.72%	469,320 $40.8 Million
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $992,108 - $2.73 Million	-26,177 Reduced 4.34%	577,419 $33.5 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $5.38 Million - $6.91 Million	69,268 Added 12.96%	603,596 $55.8 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $3.54 Million - $4.8 Million	39,149 Added 7.91%	534,328 $48.3 Million
Q2 2019 Aug 15, 2019	BUY	$89.51 - $118.04 $4.56 Million - $6.02 Million	50,987 Added 11.48%	495,179 $0
Q1 2019 May 14, 2019	BUY	$61.98 - $96.5 $749,524 - $1.17 Million	12,093 Added 2.8%	444,192 $0
Q4 2018 Feb 13, 2019	SELL	$56.04 - $82.66 $12.7 Million - $18.8 Million	-227,245 Reduced 34.47%	432,099 $27.3 Million
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $3.88 Million - $6.47 Million	-80,249 Reduced 10.85%	659,344 $0
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $3.39 Million - $6.27 Million	-89,650 Reduced 10.81%	739,593 $0
Q1 2018 May 14, 2018	SELL	$39.82 - $57.53 $1.76 Million - $2.55 Million	-44,323 Reduced 5.07%	829,243 $0
Q4 2017 Feb 09, 2018	SELL	$46.49 - $60.51 $9.25 Million - $12 Million	-199,003 Reduced 18.55%	873,566 $0
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $39.7 Million - $50.5 Million	1,072,569	1,072,569 $0

Others Institutions Holding EXAS

# of Institutions

699

Shares Held

160M

Call Options Held

5.84M

Put Options Held

2.58M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.64B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Exact Sciences Corp Transaction History